$7.62
+0.15 (+2.01%)
Open$7.67
Previous Close$7.47
Day High$7.75
Day Low$7.59
52W High$15.30
52W Low$5.29
Volume—
Avg Volume4.1K
Market Cap1.16B
P/E Ratio306.59
EPS$0.19
SectorN/A
Analyst Ratings
Strong Buy
7 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 298.44M | 264.43M | 276.45M |
| Net Income | 14.60M | 11.79M | 12.18M |
| Profit Margin | 4.9% | 4.5% | 4.4% |
| EBITDA | 27.42M | 22.09M | 25.58M |
| Free Cash Flow | 13.07M | 10.26M | 10.73M |
| Rev Growth | -8.4% | +2.2% | +6.3% |
| Debt/Equity | 0.81 | 0.83 | 0.74 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $2.96 | -7.50% | — | 2.01B |
| PICS | Pics Nv | $8.19 | -1.56% | 4.4 | 1.13B |
| DMII | Drugs Made In America Acquis | $10.18 | +0.15% | 49.7 | 646.56M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.69 | -0.19% | 42.2 | 335.42M |
| CEPF | Cantor Equity Partners-Cl A | $10.30 | +0.15% | 41.3 | 587.79M |